Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FG-4592 for anemia in incident dialysis patients
KCT0001691Phase 3Recruiting
- Sponsor
- FibroGen
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of roxadustat in anaemia, end-stage kidney disease (ESKD), sponsored by FibroGen. Started Apr 2014; status: recruiting.
02
Drugs
roxadustat
03
Conditions
anaemiaend-stage kidney disease (ESKD)
Beyond the preview
Go deeper on KCT0001691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001691.